Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)

BACKGROUND: Fibroblast growth factor 23 (FGF23) is the earliest marker of disturbed mineral metabolism as renal function decreases. Its serum levels are associated with mortality in dialysis patients, persons with chronic kidney disease (CKD) and prevalent cardiovascular disease (CVD), and it is ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Westerberg, Per-Anton, Tivesten, Åsa, Karlsson, Magnus K, Mellström, Dan, Orwoll, Eric, Ohlsson, Claes, Larsson, Tobias E, Linde, Torbjörn, Ljunggren, Östen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637557/
https://www.ncbi.nlm.nih.gov/pubmed/23587028
http://dx.doi.org/10.1186/1471-2369-14-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637557/
https://www.ncbi.nlm.nih.gov/pubmed/23587028
http://dx.doi.org/10.1186/1471-2369-14-85

Ejemplares similares